REQUEST FOR EXTENSION OF PROTECTION
SERIAL NUMBER: 79249601 FILING DATE: 09/03/2018
The table below presents the data as entered.
Input Field
|
Entered
|
| MARK SECTION |
| IMAGE |
\\TICRS\EXPORT17\IMAGEOUT17\792\496\79249601\xml1\APP0002.JPG |
| COLLECTIVE, CERTIFICATE OR GUARANTEE MARK |
NO |
| MARK IN STANDARD CHARACTERS |
YES |
| MARK IN COLOR |
NO |
| THREE DIMENSIONAL MARK |
NO |
| SOUND MARK |
NO |
| TM IMAGE: COLOR |
NO |
| IMAGE FILE NAME |
\\TICRS\EXPORT17\IMAGEOUT17\792\496\79249601\xml1\APP0002.JPG |
| TYPE (IMAGE TYPE) |
JPG |
| TEXTUAL ELEMENTS OF MARK |
SATMOBO |
| HOLDER DETAILS |
| CLIENT IDENTIFIER |
1122723 |
| NOTIFICATION LANGUAGE |
ENGLISH |
| NAME |
TAIHO PHARMACEUTICAL CO., LTD. |
| ADDRESS |
1-27 Kandanishiki-cho, |
| |
Chiyoda-ku |
| |
Tokyo 101-8444 |
| COUNTRY |
Japan |
| ENTITLEMENT NATIONALITY OF APPLICANT/TRANSFEREE/HOLDER |
Japan |
| LEGAL NATURE |
Corporation |
| LEGAL NATURE: PLACE INCORPORATED |
Japan |
| CORRESPONDENCE INDICATOR |
YES |
| LIMITATION DETAILS |
| DESIGNATED CONTRACTING PARTY CODE |
United States of America |
| GOODS AND SERVICES LIMITED TO |
05 |
| GOODS AND SERVICES LIMITED TO |
Pharmaceutical preparations for the treatment tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the
field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders;
pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations
for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of
gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and
disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system;
pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of
allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic
preparations. |
| BASIC GOODS AND SERVICES |
| VERSION OF NICE CLASSIFICATION USED |
11-2018 |
| NICE CLASSIFICATION |
05 |
| GOODS AND SERVICES |
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the
field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders;
pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations
for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of
gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and
disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system;
pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of
allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations;
pharmaceutical preparations. |
| PARIS PRIORITY DETAILS |
| PARIS PRIORITY CODE: |
Japan |
| PARIS PRIORITY APPLICATION NUMBER |
2018-105768 |
| PARIS PRIORITY APPLICATION DATE |
08/21/2018 |
| BASE REGISTRATION DETAILS |
| BASE APPLICATION NUMBER |
2018-105768 |
| BASE APPLICATION DATE |
08/21/2018 |
| REPRESENTATIVE DETAILS |
| CLIENT IDENTIFIER |
1137481 |
| NAME |
IWASE Hitomi |
| ADDRESS |
NISHIMURA & ASAHI, |
| |
Otemon Tower, |
| |
1-1-2 Otemachi, |
| |
Chiyoda-ku |
| |
Tokyo 100-8124 |
| COUNTRY |
Japan |
| INTENT TO USE GROUP |
| CONTRACTING PARTY CODE |
United States of America |
| DESIGNATIONS |
| DESIGNATIONS UNDER THE PROTOCOL |
United States of America |
| INTERNATIONAL REGISTRATION DETAILS |
| INTERNATIONAL REGISTRATION NUMBER |
1444384 |
| INTERNATIONAL REGISTRATION DATE OF MARK |
09/03/2018 |
| INTERNATIONAL REGISTRATION EXPIRY DATE |
09/03/2028 |
| EFFECTIVE DATE OF MODIFICATION |
09/03/2018 |
| NOTIFICATION DATE |
01/10/2019 |
| DATE OF RECORDAL IN INTERNATIONAL REGISTER |
12/28/2018 |
| IB DOCUMENT ID |
1188343901 |
| OFFICE OF ORIGIN CODE |
Japan |
| OFFICE REFERENCE |
79249601 |
| TRANSACTION TYPE VALUES |
Initial Designation |
| ORIGINAL LANGUAGE |
ENGLISH |
| INSTRUMENT UNDER WHICH CONTRACTING PARTY IS DESIGNATED |
Protocol |
| DURATION OF MARK (YEARS) |
10 |
